Hi everyone,
I was just curious about something. My mom is stage IIIc with positive retroperitoneal nodes. She is optimally debulked with no visible residual tumor. When we were first discussing therapy with her doctor, we were given the choice between IP therapy and the IV carbo/taxol - avastin trial.
Later, they told us that she did not qualify for the trial because she was optimally debulked so we chose IP therapy.
I was just noticing that there were a number of people on this forum who were on the trial and may have been optimally debulked. Is this correct? I was just wondering if I understood the doctor correctly and we made the right decision.
Thanks,
Anne





Add to the discussion